Track topics on Twitter Track topics that are important to you
(Institut Pasteur) The first global mapping of artemisinin resistance (the KARMA study) has definitively confirmed that resistance to the main drug currently used in the treatment of Plasmodium falcip...
Themis is a Vienna-based vaccine developer. Together with the Institut Pasteur, it is now planning to use a measles vaccine construct to develop and start Zika vaccine trials within the next 12 m...
Austria-based biotech Themis Bioscience has extended its existing license agreement with France’s Institut…
The first global mapping of artemisinin resistance (the KARMA study) has definitively confirmed that resistance to the main drug currently used in the treatment of Plasmodium falciparum malaria is for...
New worldwide, exclusive license agreement provides broad access to institut Pasteur's virus vector technology - Zika vaccine development progressing with high priority. Themis successfully extended i...
The response to infection is highly variable from one individual to another. The Milieu Intérieur consortium, coordinated by Prof. Matthew Albert (Immunobiology of dendritic cells Unit, Institut Past...
(Kumamoto University) Kumamoto University, Japan and the Institut Pasteur, France held a signing ceremony for institutional cooperation agreement followed by a workshop on reproductive engineering tec...
(Institut Pasteur) Studies have indicated that nicotine may be beneficial for memory function. Scientists from the Institut Pasteur and the CNRS set out to shed further light on the properties attribu...
Elie Metchnikoff passed away on July 15(th), 1916. He is considered to be the father of phagocytes, cellular innate immunity, probiotics, and gerontology. In all of these fields, he was a visionary. T...
Article highlight based on "Dynamic niche-specific adaptations in Neisseria meningitides during infection" by Yan Liu et al..